Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Cited by (1,000)

Items 101–200 of 1,000

1. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect
   Zahra Merali, Stephanie Ross, Guillaume Paré · 2014 · Drug metabolism and drug interactions
2. Patient outcomes using the European label for dabigatran
   Andreas Clemens, Herbert Noack, Jorge Ferreira, Stuart J. Connolly, Salim Yusuf, Gregory Y.H. Lip · 2013 · Thrombosis and Haemostasis
3. Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials
   Jonathan Douxfils, Fanny Buckinx, François Mullier, Valentine Minet, Véronique Rabenda, Jean‐Yves Reginster, Philippe Hainaut, Olivier Bruyère, Jean‐Michel Dogné · 2014 · Journal of the American Heart Association
4. Novel oral anticoagulants in gastroenterology practice
   Jay Desai, Christopher Bull Granger, Jeffrey Ian Weitz, James Aisenberg · 2013 · Gastrointestinal Endoscopy
5. Extracorporeal Therapy for Dabigatran Removal in the Treatment of Acute Bleeding
   Tripti Singh, Thin Thin Maw, Brian L. Henry, Núria M. Pastor‐Soler, Mark L. Unruh, Kenneth R. Hallows, Thomas D. Nolin · 2013 · Clinical Journal of the American Society of Nephrology
6. 2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
   Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, Toon Wei Lim, Eue‐Keun Choi, Yi‐Hsin Chan, Yutao Guo, Charn Sriratanasathavorn, Seil Oh, Ken Okumura et al. · 2021 · Journal of Arrhythmia
7. Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
   Sebastian Harder, Jochen Graff · 2013 · European Journal of Clinical Pharmacology
8. Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
   Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Keiichiro Kuronuma, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Shoji Hanada, Kazumiki Nomoto et al. · 2017 · Journal of Arrhythmia
9. Dabigatran Compared with Warfarin in Patients with Atrial Fibrillation and Symptomatic Heart Failure: A Subgroup Analysis of the RE-LY Trial
   Jorge Ferreira, Michael D. Ezekowitz, Stuart J. Connolly, Martina Brueckmann, Mandy Fraessdorf, Paul A. Reilly, Salim Yusuf, Lars C. Wallentin · 2013 · European Journal of Heart Failure
10. Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy
    Morten Lamberts, Gregory Y.H. Lip, Morten Lock Hansen, Jesper Lindhardsen, Jonas Bjerring Olesen, Jakob Raunsø, Anne‐Marie Schjerning Olsen, Per Kragh Andersen, Thomas Alexander Gerds, Emil Loldrup Fosbøl et al. · 2014 · Annals of Internal Medicine
11. Bleeding and antidotes in new oral anticoagulants
    Ammar Majeed, Sam Schulman · 2013 · Best Practice & Research Clinical Haematology
12. Meta-Analysis of Direct-Acting Oral Anticoagulants Compared With Warfarin in Patients >75 Years of Age
    Aaqib Habib Malik, Srikanth Yandrapalli, Wilbert S. Aronow, Julio A. Panza, Howard A. Cooper · 2019 · The American Journal of Cardiology
13. Dabigatran use in elderly patients with atrial fibrillation
    Meytal Avgil-Tsadok, Cynthia Anne Jackevicius, Vidal Essebag, Mark Jeffrey Eisenberg, Elham Rahme, Hassan Behlouli, Louise Pilote · 2015 · Thrombosis and Haemostasis
14. Ablation for Atrial Fibrillation in Combination With Left Atrial Appendage Closure: First Results of a Feasibility Study
    Martin John Swaans, Martijn C. Post, Benno J.W.M. Rensing, Lucas V.A. Boersma · 2012 · Journal of the American Heart Association
15. Cerebral Microbleeds on Magnetic Resonance Imaging and Anticoagulant-Associated Intracerebral Hemorrhage Risk
    Andreas Charidimou, Clare Shakeshaft, David John Werring · 2012 · Frontiers in Neurology
16. Sulfated Pentagalloylglucoside Is a Potent, Allosteric, and Selective Inhibitor of Factor XIa
    Rami A. Al‐Horani, Pooja Ponnusamy, Akul Y. Mehta, David Gailani, Umesh R. Desai · 2013 · Journal of Medicinal Chemistry
17. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
    Jan Steffel, Peter B. Verhamme, Tatjana Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Hæusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldán et al. · 2018 · Kardiologia Polska
18. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice
    Robert J. Romanelli, Laura Nolting, Marina Dolginsky, Eunice Kym, Kathleen B. Orrico · 2016 · Circulation Cardiovascular Quality and Outcomes
19. Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
    Robert G. Hart, John W. Eikelboom, Kenneth Scott Brimble, Michael Sean McMurtry, Alistair John Ingram · 2013 · Canadian Journal of Cardiology
20. Neurosurgical complications of direct thrombin inhibitors—catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran
    Sarah T. Garber, Walavan Sivakumar, Richard H. Schmidt · 2012 · Journal of neurosurgery
21. Effects of dabigatran according to age in atrial fibrillation
    Mandy N. Lauw, John W. Eikelboom, Michiel Coppens, Lars C. Wallentin, Salim Yusuf, Michael D. Ezekowitz, Jonas Oldgren, Juliet Nakamya, Jia Wang, Stuart J. Connolly · 2017 · Heart
22. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience
    John W. Eikelboom, Geno J. Merli · 2016 · The American Journal of Medicine
23. Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
    Maxim Grymonprez, Stéphane Steurbaut, Tine LM de Backer, Mirko Petrović, Lies Lahousse · 2020 · Frontiers in Pharmacology
24. Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial
    Peter M. Bytzer, Stuart J. Connolly, Sean Yang, Michael D. Ezekowitz, Stephan Formella, Paul A. Reilly, James Aisenberg · 2012 · Clinical Gastroenterology and Hepatology
25. FDA drug safety communications: a narrative review and clinical considerations for older adults
    Marcum, Zachary A., Vande Griend, Joseph P., Linnebur, Sunny A. · 2012 · The American Journal of Geriatric Pharmacotherapy
26. The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation
    Satoshi Ogawa, Kazutaka Aonuma, Hung‐Fat Tse, Dejia Huang, Jin‐Long Huang, Jonathan M. Kalman, Shiro Kamakura, Mohan Nair, Dong‐Gu Shin, Martin K. Stiles et al. · 2013 · Journal of Arrhythmia
27. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
    Ying Bai, Shi-Dong Guo, Hai Deng, Alena Shantsila, Laurent Fauchier, Changsheng Ma, Gregory Y.H. Lip · 2017 · Age and Ageing
28. Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
    Irene Savelieva, A. John Camm · 2013 · Clinical Cardiology
29. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
    Mark J. Alberts, John W. Eikelboom, Graeme J. Hankey · 2012 · The Lancet Neurology
30. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
    Maria Cecilia Bahit, Renato D. Lópes, DANIEL M. WOJDYLA, Claes Held, Michael Hanna, Dragoş Vinereanu, Elaine M. Hylek, Freek W.A. Verheugt, Shinya Goto, John Hunter Alexander et al. · 2016 · Heart
31. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry
    Nobuhiro Murata, Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Keiichiro Kuronuma, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Shoji Hanada et al. · 2019 · Circulation Journal
32. Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis
    Yan Xu, Anne Marie Holbrook, Christopher S. Simpson, Dar D Dowlatshahi, Ana P Johnson · 2013 · CMAJ Open
33. Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials
    Koon‐Hou Mak · 2012 · BMJ Open
34. Cost-Effectiveness of Community-Based Strategies for Blood Pressure Control in a Low-Income Developing Country
    Tazeen H. Jafar, Muhammad Shariful Islam, Rasool Bux, Neil R Poulter, Juanita Hatcher, Nish Chaturvedi, Shah B J Ebrahim, Peter Cosgrove · 2011 · Circulation
35. Anticoagulants in atrial fibrillation patients with chronic kidney disease
    Robert G. Hart, John W. Eikelboom, Alistair John Ingram, Charles A. Herzog · 2012 · Nature Reviews Nephrology
36. Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
    Rajiv Sankaranarayanan, Graeme J. Kirkwood, Katharine M. Dibb, Clifford J. Garratt · 2013 · Cardiology Research and Practice
37. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis
    Kochawan Boonyawat, F. Caron, Ang Li, Chatree Chai‐Adisaksopha, Wendy Lim, Alfonso Iorio, Renato D. Lópes, David A. Garcia, Mark Andrew Crowther · 2017 · Journal of Thrombosis and Haemostasis
38. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
    Olivier Hanon, Patrick Assayag, Joël Belmin, Jean‐Philippe Collet, J.P. Émeriau, Laurent Fauchier, Françoise Forette, Patrick Friocourt, Armelle Gentric, Christophe Leclercq et al. · 2013 · Archives of cardiovascular diseases
39. Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
    on behalf of Grupo de trabajo de Riesgo vascular de la SEMI, Carmen Suárez Fernández, Francesç Formiga, Miguel Camafort, J.M. Cepeda Rodrigo, Jesús Díez‐Manglano, Antonio Pose Reino, Gregorio Tiberio, José María Mostaza · 2015 · BMC Cardiovascular Disorders
40. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients
    Angelo Silverio, Marco Di Maio, Costantina Prota, Elena De Angelis, Ilaria Radano, Rodolfo Citro, Albino Carrizzo, Michele Ciccarelli, Carmine Vecchione, Davide Capodanno et al. · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
41. The Discovery of Dabigatran Etexilate
    Joanne van Ryn, Ashley Goss, Norbert H. Hauel, Wolfgang Wienen, Henning W. M. Priepke, Herbert Nar, Andreas Clemens · 2013 · Frontiers in Pharmacology
42. Novel oral anticoagulants and reversal agents: Considerations for clinical development
    Troy C. Sarich, Jonathan H. Seltzer, Scott D. Berkowitz, James C. Costin, John T. Curnutte, Charles Michael Gibson, Maureane Hoffman, Edvardas Kaminskas, Mitchell W. Krucoff, Jerrold H. Levy et al. · 2015 · American Heart Journal
43. Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
    Adrian Matthew Shields, Gregory Y.H. Lip · 2015 · Journal of Internal Medicine
44. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe
    Juhani K.E. Airaksinen, Thomas Cuisset, Francisco R. Marín, Andrea Rubboli, Andrea Rubboli, Gregory Y.H. Lip, Kurt Huber · 2011 · Thrombosis and Haemostasis
45. Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation
    John W. Eikelboom, Stuart J. Connolly, Robert G. Hart, Lars C. Wallentin, Paul A. Reilly, Jonas Oldgren, Sean Yang, Salim Yusuf · 2013 · Journal of the American College of Cardiology
46. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)
    Maurizio Giuseppe Abrignani, Luigi Gatta, Domenico Gabrielli, Giuseppe Milazzo, Vincenzo De Francesco, Leonardo De Luca, Maura Francese, Massimo Imazio, Elisabetta Riccio, Roberta Rossini et al. · 2020 · European Journal of Internal Medicine
47. Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients – Insight From the Fushimi AF Registry –
    Yasuhiro Hamatani, Hisashi Ogawa, Ryuji Uozumi, Moritake Iguchi, Yugo Yamashita, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa et al. · 2015 · Circulation Journal
48. Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review
    Chatree Chai‐Adisaksopha, Christopher Hillis, Wendy Lim, Kochawan Boonyawat, Karen A. Moffat, Mark Andrew Crowther · 2015 · Journal of Thrombosis and Haemostasis
49. Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology—Cardiovascular Round Table
    Maddalena Lettino, Julia Mascherbauer, Matias Nordaby, André Ziegler, Jean‐Philippe Collet, Geneviève Dérumeaux, Stefan Hans Hohnloser, Christophe Leclercq, Deirdre E. O’Neill, Frank L.J. Visseren et al. · 2022 · European Journal of Preventive Cardiology
50. Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
    Brian J. Dale, John W. Eikelboom, Jeffrey Ian Weitz, Ed Young, Jeremy S. Paikin, Michiel Coppens, Richard Paul Whitlock, Stuart J. Connolly, Jeffrey S. Ginsberg, Jack Hirsh · 2012 · Journal of Thrombosis and Thrombolysis
51. Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
    Jean‐Pierre Bassand, Saverio Virdone, Marc Badoz, Freek W.A. Verheugt, A. John Camm, Frank J.S. Cools, Keith A.A. Fox, Samuel Zachary Goldhaber, Shinya Goto, Sylvia K. Haas et al. · 2021 · Blood Advances
52. New oral anticoagulants in elderly patients
    Stefano Barco, Y. Whitney Cheung, John W. Eikelboom, Michiel Coppens · 2013 · Best Practice & Research Clinical Haematology
53. How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
    Jordan K. Schaefer, Robert D. McBane, Waldemar E. Wysokiński · 2015 · Annals of Hematology
54. New direct oral anticoagulants – current therapeutic options and treatment recommendations for bleeding complications
    Erhard Seifried, Wolfgang Miesbach · 2012 · Thrombosis and Haemostasis
55. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
    Diana Adrienne Gorog, Ying Xuan Gue, Tze‐Fan Chao, Laurent Fauchier, José Luis Ferreiro, Kurt Huber, Stavros Konstantinides, Deirdre A. Lane, Francisco R. Marín, Jonas Oldgren et al. · 2022 · EP Europace
56. Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?
    Andreas Clemens, Andreas Strack, Herbert Noack, Stavros Konstantinides, Martina Brueckmann, Gregory Y.H. Lip · 2014 · Annals of Medicine
57. Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials
    Thomas Vanassche, Jack Hirsh, Jeffrey S. Ginsberg, John W. Eikelboom · 2014 · Thrombosis and Haemostasis
58. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants
    Charles V. Pollack, Jeffrey Ian Weitz · 2015 · Thrombosis and Haemostasis
59. Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants
    Daniel Caldeira, Márcio Barra, A. Ferreira, A. Rocha, Abrahão Augusto, Fausto José Pinto, João N. Costa, Joaquim José Ferreira · 2015 · Alimentary Pharmacology & Therapeutics
60. New oral anticoagulant agents – general features and outcomes in subsets of patients
    Sam Schulman · 2014 · Thrombosis and Haemostasis
61. The Impact of Age on the Epidemiology of Atrial Fibrillation Hospitalizations
    Sahar Naderi, Yun Wang, Amy Leigh Miller, Fátima Rodríguez, Mina K. Chung, Martha J. Radford, JoAnne Micale Foody · 2013 · The American Journal of Medicine
62. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation
    Gaetano Michele Fassini, Sergio Conti, Massimo Moltrasio, Anna C. Maltagliati, Fabrizio Tundo, Stefania I. Riva, Antonio Dello Russo, Michela Casella, Benedetta Majocchi, Martina Zucchetti et al. · 2016 · EP Europace
63. A comparison of bleeding complications post-ablation between warfarin and dabigatran
    David Snipelisky, Christine Bienvenue Kauffman, Karin A. Prussak, Gretchen Schaef Johns, K.L. Venkatachalam, Fred M Kusumoto · 2012 · Journal of Interventional Cardiac Electrophysiology
64. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke
    Waltraud Pfeilschifter, Ferdinand Oliver Bohmann, Peter Baumgarten, Michel Guy André Mittelbronn, Josef M. Pfeilschifter, Edelgard Lindhoff‐Last, Helmuth Steinmetz, Christian Foerch · 2012 · Annals of Neurology
65. Safety of new oral anticoagulant drugs: a perspective
    Juan Antonio Vilchez, Pilar Gallego, Gregory Y.H. Lip · 2013 · Therapeutic Advances in Drug Safety
66. The pharmacology of novel oral anticoagulants
    Tracy A. DeWald, Richard Clinton Becker · 2013 · Journal of Thrombosis and Thrombolysis
67. Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation
    Kathryn Friedman Flack, Jay Desai, Jennifer M. Kolb, Prapti Chatterjee, Lars C. Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, Paul A. Reilly, Martina Brueckmann et al. · 2016 · Clinical Gastroenterology and Hepatology
68. Acute, periprocedural and longterm antithrombotic therapy in older adults
    Felicita Andreotti, Tobias Geisler, Jean‐Philippe Collet, Bruna Gigante, Diana Adrienne Gorog, Sigrun Halvorsen, Gregory Y.H. Lip, João Morais, Eliano Pio Navarese, Carlo Patrono et al. · 2022 · European Heart Journal
69. Use of anticoagulants in elderly patients
    Rupert Martin Bauersachs · 2011 · Thrombosis Research
70. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: A review of the literature
    Cecilia Becattini, Maria Cristina Vedovati, Giancarlo Agnelli · 2012 · Thrombosis Research
71. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis
    In‐Soo Kim, Hyun-Jung Kim, Tae‐Hoon Kim, Jae‐Sun Uhm, Boyoung Joung, Moon‐Hyoung Lee, Hui‐Nam Pak · 2018 · Journal of Cardiology
72. Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
    Giuseppe Patti, Ladislav Pecen, Markus Lucerna, Kurt Huber, Miklós Rohla, Giulia Renda, Jolanta Maria Siller-Matula, Fabrizio Ricci, Paulus F. Kirchhof, Raffaele De Caterina · 2019 · The American Journal of Medicine
73. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation
    Meytal Avgil Tsadok, Cynthia Anne Jackevicius, Elham Rahme, Karin H. Humphries, Louise Pilote · 2015 · Circulation Cardiovascular Quality and Outcomes
74. Risk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-Analysis
    Joel Skaistis, Travis Tagami · 2015 · PLoS ONE
75. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
    A. Wolff, Eduard Shantsila, Gregory Y.H. Lip, Deirdre A. Lane · 2015 · Age and Ageing
76. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
    Fernándo Domínguez, Vicente E Climent, Esther Zorio, Tomás Ripoll‐Vera, Joel Salazar‐Mendiguchía, José Manuel García‐Pinilla, José Ángel Urbano-Moral, Xusto Fernández, David López-Cuenca, Raquel Ajo et al. · 2017 · International Journal of Cardiology
77. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin
    Adrian A. Maung, Bishwajit Bhattacharya, Kevin M. Schuster, Kimberly A. Davis · 2016 · The Journal of Trauma: Injury, Infection, and Critical Care
78. Non-Vitamin K Antagonist Oral Anticoagulants Do Not Increase Cerebral Microbleeds
    Tsukasa Saito, Yuichiro Kawamura, Nobuyuki Sato, Kohei Kano, Kae Takahashi, Asuka Asanome, Jun Sawada, Takayuki Katayama, Naoyuki Hasebe · 2015 · Journal of Stroke and Cerebrovascular Diseases
79. Factors Affecting Patients’ Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants
    Ekta Pandya, Beata V. Bajorek · 2016 · Patient
80. Treatment Discontinuations With New Oral Agents for Long-term Anticoagulation: Insights From a Meta-analysis of 18 Randomized Trials Including 101,801 Patients
    Saurav Chatterjee, Partha Sardar, Jay S. Giri, Joydeep Ghosh, Debabrata Mukherjee · 2014 · Mayo Clinic Proceedings
81. The Management of Antithrombotic Medication in Skin Surgery
    Shields Callahan, Anne Goldsberry, Glen Kim, Simon S. Yoo · 2012 · Dermatologic Surgery
82. Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study
    Gregory Y.H. Lip, Allison V. Keshishian, Amiee Luan Kang, Amol D. Dhamane, Xuemei Luo, X. Li, N. Balachander, Lisa C. Rosenblatt, Jack Mardekian, Xiangbin Pan et al. · 2020 · Journal of Internal Medicine
83. Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
    Steven Bruce Deitelzweig, Allison V. Keshishian, Xiaoyan Li, Amiee Luan Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa C. Rosenblatt, Jack Mardekian, Xianying Pan et al. · 2019 · Journal of the American Geriatrics Society
84. Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation
    Peter Sinnaeve, Martina Brueckmann, Andreas Clemens, Jonas Oldgren, John W. Eikelboom, J. Healey · 2011 · Journal of Internal Medicine
85. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
    Andreas Schäfer, Ulrike Flierl, Dominik Berliner, Johann K Bauersachs · 2020 · Cardiovascular Drugs and Therapy
86. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions
    Jeremy S. Paikin, Jack Hirsh, Mandy N. Lauw, John W. Eikelboom, Jeffrey S. Ginsberg, Noel Chan · 2014 · Thrombosis and Haemostasis
87. Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
    Fabiana Lucà, Fabrizio Giovanni Oliva, Maurizio Giuseppe Abrignani, Stefania Angela Di Fusco, Iris Parrini, Maria Laura Canale, Simona Giubilato, Stefano Cornara, Martina Nesti, Carmelo Massimiliano Rao et al. · 2023 · Journal of Clinical Medicine
88. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications
    Fulvia Costantinides, Roberto Rizzo, Lorenzo Pascazio, Michele Maglione · 2016 · BMC Oral Health
89. Minimizing the Risk of Bleeding with NOACs in the Elderly
    Amartya Kundu, Partha Sardar, Saurav Chatterjee, Wilbert S. Aronow, Theophilus Owan, John Jake Ryan · 2016 · Drugs & Aging
90. Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
    Anneka Mitchell, Margaret C Watson, Tomas James Welsh, Anita McGrogan · 2019 · Journal of Clinical Medicine
91. Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants
    Yan Xu, Deborah M. Siegal · 2021 · Journal of Thrombosis and Haemostasis
92. Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis
    Nicholas Ewin Burr, Katie Lummis, Ruchit Sood, John S. Kane, Venkataraman Subramanian · 2016 · The Lancet. Gastroenterology & hepatology
93. Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II
    Samuel Zachary Goldhaber, Sam Schulman, Henry Eriksson, Martin Feuring, Mandy Fraessdorf, Jörg Kreuzer, Elke Schueler, Sebastian Schellong, Ajay K. Kakkar · 2017 · Thrombosis and Haemostasis
94. Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
    Colleen M. Hanley, Peter Russell Kowey · 2015 · Europe PMC (PubMed Central)
95. Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis
    Liang Lin, Wee Shiong Lim, Hui Jun Zhou, Ai Leng Khoo, Keng Teng Tan, Aik Phon Chew, David Chee Guan Foo, Jing Jih Chin, Boon Peng Lim · 2015 · Journal of the American Medical Directors Association
96. Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
    Paul P. Dobesh, John R. Fanikos · 2015 · Drugs
97. Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
    Tatjana Potpara, Gregory Y.H. Lip · 2015 · Progress in Cardiovascular Diseases
98. A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    Stephen A. LaHaye, Sabra Lynn Gibbens, David G. A. Ball, Andrew G. Day, Jonas Bjerring Olesen, Allan Cameron Skanes · 2012 · European Heart Journal
99. New oral anticoagulants: which one should my patient use?
    Jeffrey Ian Weitz, Peter L. Gross · 2012 · Hematology
100. Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation
     Eri Toda Kato, Shinya Goto, Robert Patrick Giugliano · 2018 · Ageing Research Reviews